AP NEWS

Gilead Sciences to Release Third Quarter 2018 Financial Results on Thursday, October 25, 2018

October 11, 2018

FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct 11, 2018--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2018 financial results will be released on Thursday, October 25, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s financial results for the third quarter 2018 and provide a general business update.

The live webcast of the call can be accessed at the company’s Investors page at www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the call to ensure adequate time for any software download that may be required to listen to the webcast. Alternatively, please call 877-359-9508 (U.S.) or 224-357-2393 (international) and dial the conference ID 1789278 to access the call. Telephone replay will be available approximately two hours after the call through 11:59 p.m. Eastern Time, October 27, 2018. To access the replay, please call 855-859-2056 (U.S.) or 404-537-3406 (international) and dial the conference ID 1789278. The webcast will be archived on www.gilead.com for one year.

About Gilead

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181011005875/en/

CONTACT: Gilead Sciences, Inc.

Sung Lee, 650-524-7792

Investor Relations

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY HOSPITALS PHARMACEUTICAL

SOURCE: Gilead Sciences, Inc.

Copyright Business Wire 2018.

PUB: 10/11/2018 04:05 PM/DISC: 10/11/2018 04:05 PM

http://www.businesswire.com/news/home/20181011005875/en

AP RADIO
Update hourly